Stock Detail
Videos
Aytu BioPharma (AYTU) Company Webcast
Aytu BioPharma (Nasdaq: AYTU) is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. This company webcast was recorded during the Lytham Partners Fall 2025 Investor...
Aytu BioPharma (AYTU) Fireside Chat
During this fireside chat we welcome Aytu BioPharma (Nasdaq: AYTU). Aytu is a pharmaceutical company focused on commercializing novel therapeutics. This fireside chat was recorded during the Lytham Partners 2025 Investor Healthcare Summit.
Aytu BioPharma (AYTU) Fireside Chat
In this discussion, we welcome Aytu BioPharma, NASDAQ ticker symbol AYTU. And with us today is their Chief Executive Officer, Josh Disbrow. Aytu is a pharmaceutical company focused on commercializing novel therapeutics. This Fireside Chat was recorded during the...
News
Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
DENVER, CO / ACCESS Newswire / November 24, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients,...
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
Total net revenue of $13.9 millionNet income of $2.0 million, or $0.21 net income per share basicAdjusted EBITDA1 of $(0.6) million, which includes EXXUA launch investments$32.6 million cash balance at September 30, 2025Company remains on track to launch EXXUA™...
Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025
DENVER, CO / ACCESS Newswire / November 5, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients,...